|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PLA2G2A |
Top |
Phenotypic Information for PLA2G2A(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: PLA2G2A |
Familial Cancer Database: PLA2G2A |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM KEGG_ARACHIDONIC_ACID_METABOLISM KEGG_LINOLEIC_ACID_METABOLISM KEGG_ALPHA_LINOLENIC_ACID_METABOLISM REACTOME_PHOSPHOLIPID_METABOLISM REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Mutations for PLA2G2A |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
There's no structural variation information in COSMIC data for this gene. |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PLA2G2A related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AI418780 | PLA2G2A | 1 | 66 | 1 | 20301929 | 20301994 | MLLT4 | 62 | 455 | 6 | 168352373 | 168352766 | |
BQ326672 | GFRA1 | 1 | 115 | 10 | 117817772 | 117817887 | PLA2G2A | 105 | 337 | 1 | 20304519 | 20305012 | |
BE646307 | PLA2G2A | 1 | 66 | 1 | 20301929 | 20301994 | MLLT4 | 62 | 431 | 6 | 168352397 | 168352766 | |
AI805196 | PLA2G2A | 1 | 66 | 1 | 20301929 | 20301994 | MLLT4 | 62 | 431 | 6 | 168352397 | 168352766 | |
CB050783 | PLA2G2A | 23 | 89 | 1 | 20301928 | 20301994 | MLLT4 | 85 | 488 | 6 | 168352363 | 168352766 |
![]() |
Top |
![]() |
There's no copy number variation information in COSMIC data for this gene. |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=11) | (# total SNVs=4) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:20304926-20304926 | p.Y44Y | 2 |
chr1:20302244-20302244 | p.Y129H | 2 |
chr1:20304910-20304910 | p.V50M | 1 |
chr1:20302256-20302256 | p.Y125N | 1 |
chr1:20304920-20304920 | p.C46C | 1 |
chr1:20302318-20302318 | p.R104K | 1 |
chr1:20304510-20304510 | p.C97F | 1 |
chr1:20304940-20304940 | p.S40G | 1 |
chr1:20304521-20304521 | p.S93S | 1 |
chr1:20304946-20304946 | p.A38T | 1 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 |   |   |   |   |   |   |   |   |   |   | 5 | 1 |   |   | 1 | 3 | 1 |   |   |
# mutation | 1 |   |   |   |   |   |   |   |   |   |   | 5 | 1 |   |   | 1 | 3 | 1 |   |   |
nonsynonymous SNV | 1 |   |   |   |   |   |   |   |   |   |   | 5 | 1 |   |   | 1 | 2 | 1 |   |   |
synonymous SNV |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 |   |   |   |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:20304528 | p.C63S,PLA2G2A | 1 |
chr1:20304610 | p.R62C,PLA2G2A | 1 |
chr1:20304613 | p.S40R,PLA2G2A | 1 |
chr1:20304874 | p.G34E,PLA2G2A | 1 |
chr1:20304940 | p.K30N,PLA2G2A | 1 |
chr1:20304957 | p.I12I,PLA2G2A | 1 |
chr1:20304968 | p.R138K,PLA2G2A | 1 |
chr1:20302216 | p.Y125N,PLA2G2A | 1 |
chr1:20305231 | p.R104K,PLA2G2A | 1 |
chr1:20302256 | p.C97F,PLA2G2A | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PLA2G2A |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
AHSG,APOA1,APOB,CALCA,F11,G6PC,GLTPD2, GUCY2GP,HP,KNG1,LOC154822,PLA2G2A,PLA2G4A,SAA1, SERPINA7,SLC17A2,SLC22A2,SLC22A3,SLC2A2,SPP2,WNT1 | ACSM2A,ACSM2B,AMN,APOC3,APOL4,TBATA,CHGA, CPO,DBH,ELFN1,NDRG4,ORM1,PDZD7,PHOX2B, PLA2G2A,PMM1,PQLC1,RASL10B,SNORA14A,ST8SIA3,TH | ||||
![]() | |||||
B3GNT7,CA9,MCU,DOC2B,ERO1L,FAM46A,FAM69C, HPSE,MTUS1,MUC1,PGAM1,PGC,PLA2G2A,PLAC8, PLK2,PPY,RARRES1,SLC6A14,TBC1D21,TNIP3,ZMYND15 | APOL4,CD274,CXCL10,CXCL5,ERP27,FCGR1A,FCGR1B, FCGR1C,HAPLN3,IDO1,IL22,LOC400759,LYPD5,MMP1, PAQR9,PLA2G2A,PLA2G3,SOCS1,TNFSF13B,V |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for PLA2G2A |
![]() |
DB Category | DB Name | DB's ID and Url link |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00328 | phospholipase A2, group IIA (platelets, synovial fluid) | approved; investigational | Indomethacin | ![]() | ![]() |
DB00586 | phospholipase A2, group IIA (platelets, synovial fluid) | approved | Diclofenac | ![]() | ![]() |
DB01955 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 1,4-Butanediol | ![]() | ![]() |
DB02080 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene | ![]() | ![]() |
DB02448 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | N-Tridecanoic Acid | ![]() | ![]() |
DB02504 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | [3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid | ![]() | ![]() |
DB02936 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid | ![]() | ![]() |
DB03121 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid | ![]() | ![]() |
DB03471 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid | ![]() | ![]() |
DB03784 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | Elaidoylamide | ![]() | ![]() |
DB04112 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | 1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide | ![]() | ![]() |
DB04287 | phospholipase A2, group IIA (platelets, synovial fluid) | experimental | (S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid | ![]() | ![]() |
DB04786 | phospholipase A2, group IIA (platelets, synovial fluid) | approved | Suramin | ![]() | ![]() |
DB00435 | phospholipase A2, group IIA (platelets, synovial fluid) | approved | Nitric Oxide | ![]() | ![]() |
DB00482 | phospholipase A2, group IIA (platelets, synovial fluid) | approved; investigational | Celecoxib | ![]() | ![]() |
Top |
Cross referenced IDs for PLA2G2A |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |